ASFX (American Scientific Resources) Debt-to-EBITDA : -2.74 (As of Sep. 2011)


What is American Scientific Resources Debt-to-EBITDA?

American Scientific Resources ASFX -96.67% Debt-to-EBITDA is -2.74 as of Sep. 2011.

Debt-to-EBITDA measures a company's ability to pay off its debt.

American Scientific Resources's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2011 was $3.77 Mil. American Scientific Resources's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2011 was $2.41 Mil. American Scientific Resources's annualized EBITDA for the quarter that ended in Sep. 2011 was $-2.25 Mil. American Scientific Resources's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2011 was -2.74.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for American Scientific Resources's Debt-to-EBITDA or its related term are showing as below:

ASFX's Debt-to-EBITDA is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.555
* Ranked among companies with meaningful Debt-to-EBITDA only.

American Scientific Resources  (OTCPK:ASFX) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

American Scientific Resources Debt-to-EBITDA Related Terms

American Scientific Resources Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for American Scientific Resources's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

American Scientific Resources Debt-to-EBITDA Chart

American Scientific Resources Annual Data
Trend
Debt-to-EBITDA

American Scientific Resources Quarterly Data
Sep10 Sep11
Debt-to-EBITDA 0.00 -2.74

ASFX vs GNID, QTXB, ASNB: Debt-to-EBITDA Comparison

For the Medical Instruments & Supplies subindustry, American Scientific Resources's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

American Scientific Resources Debt-to-EBITDA vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, American Scientific Resources's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where American Scientific Resources's Debt-to-EBITDA falls into.


American Scientific Resources Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

American Scientific Resources's Debt-to-EBITDA for the fiscal year that ended in . 20 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=( + ) / N/A
=N/A

American Scientific Resources's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2011 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(3.77 + 2.409) / -2.252
=-2.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Sep. 2011) EBITDA data.

Frequently Asked Questions Learn more about Debt-to-EBITDA →
What does a Debt-to-EBITDA of -2.74 mean?
American Scientific Resources (ASFX) has a Debt-to-EBITDA of -2.74 as of Sep. 2011. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on American Scientific Resources.
Is American Scientific Resources' Debt-to-EBITDA too high?
American Scientific Resources' current Debt-to-EBITDA is -2.74.
How does American Scientific Resources' Debt-to-EBITDA compare to GNID and QTXB?
American Scientific Resources' Debt-to-EBITDA of -2.74 can be compared against companies in the Medical Devices & Instruments industry. The industry median Debt-to-EBITDA is 1.56. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Medical Devices & Instruments company?
The median Debt-to-EBITDA among Medical Devices & Instruments companies is 1.56, based on 468 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on American Scientific Resources. For the Medical Devices & Instruments industry, the median Debt-to-EBITDA is 1.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. American Scientific Resources's current Debt-to-EBITDA is -2.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is American Scientific Resources stock overvalued right now?
American Scientific Resources (ASFX) has a current Debt-to-EBITDA of -2.74. The current Debt-to-EBITDA is -2.74. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For American Scientific Resources (ASFX), the current Debt-to-EBITDA is -2.74 as of Sep. 2011. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

American Scientific Resources Business Description